Encore Medical, L.P.
22
1
1
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
31.8%
7 terminated/withdrawn out of 22 trials
58.8%
-27.7% vs industry average
14%
3 trials in Phase 3/4
50%
5 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
Role: lead
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
Role: collaborator
Post Market Study of the 3DKnee™ With E-plus Insert
Role: lead
The Influence of Repairing the Sub-scapularis on Outcomes After Reverse Arthroplasty
Role: lead
CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures
Role: lead
A Retrospective Study to Examine the Effect of CMF Stimulation on Primary ACDF Patients
Role: lead
Reverse Shoulder Prosthesis Prospective Multi-Center Study
Role: lead
Post-Market Study of the 3DKnee™ System
Role: lead
Post-Market Study of the Modular Revision Hip System
Role: lead
Cementless Alumina-Alumina Total Hip and Hybrid
Role: lead
Early Feasibility Study of the Percutaneous Osseointegrated Prosthesis (POP)
Role: lead
Encore Revelation Hip Stem
Role: lead
Long Term Foundation Knee Study
Role: lead
Post-Market Study of the EPIK Knee System
Role: lead
Mobile - Bearing Knee Study
Role: lead
Reverse Shoulder Prosthesis Study
Role: lead
The 3DKnee™ System: A Post-Market Study
Role: lead
Foundation Knee Study - Retrospective
Role: lead
Efficacy of the CLP® Hip - Retrospective
Role: lead
Retrospective Study of the Linear™ Hip
Role: lead